Isoxazolo[3,4-b]quinoline-3,4(1H,9H)-diones as unique, potent and selective inhibitors for Pim-1 and Pim-2 kinases: Chemistry, biological activities, and molecular modeling

This publication has 16 references indexed in Scilit:

• The survival kinases Akt and Pim as potential pharmacological targets
  Journal of Clinical Investigation, 2005
• Pim-1 Ligand-bound Structures Reveal the Mechanism of Serine/Threonine Kinase Inhibition by LY294002
  Journal of Biological Chemistry, 2005
• Structural Basis of Constitutive Activity and a Unique Nucleotide Binding Mode of Human Pim-1 Kinase
  Journal of Biological Chemistry, 2005
• The Pim kinases control rapamycin-resistant T cell survival and activation
  Journal of Experimental Medicine, 2005
• Increased Expression of thehPim-2Gene In Human Chronic lymphocytic Leukemia and Non-Hodgkin Lymphoma
  Leukemia & Lymphoma, 2004
• Pim‐1 expression in prostatic intraepithelial neoplasia and human prostate cancer
  The Prostate, 2004
• High-throughput retroviral tagging to identify components of specific signaling pathways in cancer
  Nature Genetics, 2002
• The human protooncogene product p33pim is expressed during fetal hematopoiesis and in diverse leukemias.
  Proceedings of the National Academy of Sciences, 1989
• Predisposition to lymphomagenesis in pim-1 transgenic mice: Cooperation with c-myc and N-myc in murine leukemia virus-induced tumors
  Cell, 1989
• Murine leukemia virus-induced T-cell lymphomagenesis: Integration of proviruses in a distinct chromosomal region
  Cell, 1984